Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: Role of protein kinase A and phospholipase C

Hypertension

Volumn 47, Issue 3 II, 2006, Pages 580-585

  Li, Xiao C ^a   Carretero, Oscar A ^a   Shao, Yuan ^a   Zhuo, Jia L ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Calcium; Cyclic AMP; Diabetes mellitus; Glomerulosclerosis; Insulin resistance; Kidney

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; GLUCAGON; GLUCAGON DERIVATIVE; GLUCAGON RECEPTOR; GLUCAGON RECEPTOR ANTAGONIST; GLUCAGON[1 DESHISTIDINE 9 GLUTAMIC ACID] AMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; UNCLASSIFIED DRUG; CYCLIC AMP; THYMIDINE;

ANIMAL CELL; CALCIUM SIGNALING; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLOMERULOSCLEROSIS; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGENOLYSIS; INSULIN RESISTANCE; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; INTRACELLULAR MEMBRANE; MESANGIUM; METABOLISM; OSMOLARITY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLOMERULAR MESANGIUM; GLUCAGON; INTRACELLULAR MEMBRANES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSMOLAR CONCENTRATION; PHOSPHOLIPASE C; PHOSPHORYLATION; RATS; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; THYMIDINE; TIME FACTORS;

EID: 33644987298     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000197946.81754.0a     Document Type: Conference Paper

References (30)

1. Bromer WW, Sinn LG, Staub A, Behrens OK. The amino acid sequence of glucagon. J Am Chem Soc. 1956;78:3858-3859.
2. Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, Drucker DJ. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003;55:167-194.
3. Matthaei S, Stumvoll M, Kellerer M, Haring H-U. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev. 2000;21:585-618.
4. Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB. Documentation of hyperglucagonemia through the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1987;64:106-110.
5. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2000;85:4053-4059.
6. Orskov C, Jeppesen J, Madsbad S, Holst JJ. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest. 1991;87:415-423.
7. Unger RH, Orci L. The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet. 1975;4:14-16.
8. Ahloulay M, Decaux M, Laborde K, Bankir L. Influence of glucagon on GFR and on urea and electrolyte excretion: direct and indirect effects. Am J Physiol. 1995;38:F225-F235.
9. Harris PJ, Skinner SL, Zhuo JL. The effects of atrial natriuretic peptide and glucagon on proximal glomerulotubular balance in anesthetized rats. J Physiol (Lond). 1988;402:29-42.
10. Premen AJ, Hall JE, Smith LJ. Postprandial regulation of renal hemodynamics: role of pancreatic glucagon. Am J Physiol. 1985;248:F656-F662.
11. Tolins JP. Mechanisms of glucagon-induced renal vasodilation: role of prostaglandins and endothelium-derived relaxing factor. J Lab Clin Med. 2004;120:941-948.
12. Ahloulay M, Bankir L Glucagon antibody infusion reduces GFR in diabetic rats. J Am Soc Nephrol. 1996;7:1868a (abstract).
13. Hostetter TH. Hyperfiltration and glomerulosclerosis. Semin Nephrol. 2003;23:194-199.
14. Tsiani E, Lekas P, Fantus IG, Dlugosz J, Whiteside C. High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, Ang II, and platelet-derived growth factor. Am J Physiol Endocrinol Metab. 2002;282:E161-E169.
15. 125I]glucagon binding in rat tubules. Pflugers Arch. 1985;404:348-353.
16. Marks J, Debnam ES, Dashwood MR, Srai SK, Unwin RJ. Detection of glucagon receptor mRNA in the rat proximal tubule: potential role for glucagon in the control of renal glucose transport. Clin Sci. 2003;104:253-258.
17. 2+ influx through L-type voltage-gated calcium channels mediated raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta cells. J Biol Chem. 2003;277:48146-48151.
18. Ahloulay M, Dechaux M, Hassler C, Bouby N, Bankir L. Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats. J Clin Invest. 1996;98:2251-2258.
19. Schelling JR, Hanson AS, Marzec R, Linas SL. Cytoskeleton-dependent endocytosis is required for apical type 1 angiotensin II receptor-mediated phospholipase C activation in cultured rat proximal tubule cells. J Clin Invest. 1992;90:2472-2480.
20. 2+ signaling in BHK cells expressing cloned human glucagon receptors. Am J Physiol. 1998;274:C1552-C1562.
21. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high gluocse. Kidney Int. 2002;61:1605-1616.
22. Jiang Y, Cypess AM, Muse ED, Wu C-R, Unson CG, Merrifield RB, Sakmar TP. Glucagon receptor activates extracellular signal-regulated protein kinase 1/2 via cAMP-dependent protein kinase. Proc Natl Acad Sci U S A. 2001;98:10102-10107.
23. Handa M, Arraki S, Togawa M. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes. 1997;46:847-853.
24. Abrahamsen N, Lundgren K, Nishimura E. Regulation of glucagon receptor mRNA in cultured primary rat hepatocytes by glucose and cAMP. J Biol Chem. 1995;270:15853-15857.
25. Zhuo JL, Harris PJ, Skinner SL. ACE inhibition prevents glucagon-induced glomerular hyperfiltration in anesthetized rats. FASEB J. 2003;17:A923 (abstract).
26. Amiri F, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. Hyperglycemia enhances angiotensin II-induced Janus-activated kinase/STAT signaling in vascular smooth muscle cells. J Biol Chem. 1999;274:32382-32386.
27. Kang MJ, Wu X, Ly H. Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. Kidney Int. 1999;55:2203-2214.
28. 2 signal cascade in renal proximal tubule cells. Kidney Int. 2002;61:913-925.
29. Dalle S, Longuet C, Costes S, Broca C, Faruque O, Fontes G, Hani EH, Bataille D. Glucagon promotes cAMP-response element-binding protein phosphorylation via activation of ERK 1/2 in MIN6 cell line and isolated islets of Langerhans. J Biol Chem. 2004;279:20345-20355.
30. Kemp DM, Habener JF. Insulinotrophic hormone glucagon-like peptide 1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase. Endocrinology. 2001;142:1179-1187.